P.03.14 COMBINED THERAPY WITH LOW DOSE HEPATITIS B IMMUNOGLOBULIN AND LAMIVUDINE IN PATIENTS TRANSPLANTED FOR HBV END STAGE LIVER DISEASE: STILL COST-EFFECTIVE?

✍ Scribed by M. Giusto; V. Di Gregorio; V. Giannelli; C. Lucidi; M. Rossi; G. Mennini; F. Melandro; S. Ginanni Corradini; A.F. Attili; M. Merli

• Book ID: 118648497
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 131 KB
• Volume: 44
• Category: Article
• ISSN: 1590-8658
• DOI: 10.1016/s1590-8658(12)60281-3